Our results demonstrate that patients with features of ACO displayed distinct features, they had lower plasma YKL-40 than COPD patients and a moderate elevated plasma level of NGAL compared with asthma patients; had an intermediate degree of airflow obstruction, bronchodilator response and emphysema between patients with COPD and asthma. This evidence concerns the gene LCN2 and asthma.